These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model. Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751 [TBL] [Abstract][Full Text] [Related]
24. Characterization of Chicken IgY Specific to Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119 [No Abstract] [Full Text] [Related]
25. Effects of the short-term administration of Cui S; Jiang J; Li B; Ross RP; Stanton C; Zhao J; Zhang H; Yang B; Chen W Food Funct; 2021 Mar; 12(4):1695-1707. PubMed ID: 33502422 [TBL] [Abstract][Full Text] [Related]
26. Selection of a candidate probiotic strain of Pediococcus pentosaceus from the faecal microbiota of horses by in vitro testing and health claims in a mouse model of Salmonella infection. Silva BC; Sandes SH; Alvim LB; Bomfim MR; Nicoli JR; Neumann E; Nunes AC J Appl Microbiol; 2017 Jan; 122(1):225-238. PubMed ID: 27813217 [TBL] [Abstract][Full Text] [Related]
28. Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium. Panpetch W; Somboonna N; Palasuk M; Hiengrach P; Finkelman M; Tumwasorn S; Leelahavanichkul A PLoS One; 2019; 14(1):e0210798. PubMed ID: 30645630 [TBL] [Abstract][Full Text] [Related]
29. A Spore-Forming Probiotic Supplement Improves the Intestinal Immune Response and Protects the Intestinal Health During Recurrent Clostridioides difficile Colonization in Mice. Ramezani Kapourchali F; Glueck B; Han Y; Shapiro D; Fulmer CG; Cresci GAM JPEN J Parenter Enteral Nutr; 2020 Nov; 44(8):1428-1438. PubMed ID: 32495964 [TBL] [Abstract][Full Text] [Related]
30. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis? Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052 [TBL] [Abstract][Full Text] [Related]
31. Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model. Geeraerts S; Ducatelle R; Haesebrouck F; Van Immerseel F J Gastroenterol Hepatol; 2015 Aug; 30(8):1275-80. PubMed ID: 25800047 [TBL] [Abstract][Full Text] [Related]
32. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice. Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537 [No Abstract] [Full Text] [Related]
34. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108 [TBL] [Abstract][Full Text] [Related]
35. The role of probiotic exopolysaccharides in adhesion to mucin in different gastrointestinal conditions. Lu Y; Han S; Zhang S; Wang K; Lv L; McClements DJ; Xiao H; Berglund B; Yao M; Li L Curr Res Food Sci; 2022; 5():581-589. PubMed ID: 35340998 [TBL] [Abstract][Full Text] [Related]
36. Schäffler H; Breitrück A Front Microbiol; 2018; 9():646. PubMed ID: 29692762 [No Abstract] [Full Text] [Related]
37. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection. Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094 [TBL] [Abstract][Full Text] [Related]
38. Protective Effect of Carvacrol against Gut Dysbiosis and Mooyottu S; Flock G; Upadhyay A; Upadhyaya I; Maas K; Venkitanarayanan K Front Microbiol; 2017; 8():625. PubMed ID: 28484429 [TBL] [Abstract][Full Text] [Related]